Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebif Satisfaction in MS Patients Discontinuing Tecfidera
NCT02117050Phase 4Terminated
- Sponsor
- EMD Serono
- Start
- Jun 2014
- Primary completion
- Apr 2015
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of interferon beta in multiple sclerosis (MS), sponsored by EMD Serono. Primary endpoint: Treatment Satisfaction Questionnaire for Medication Global Satisfaction Score at 24 weeks. Started Jun 2014; status: terminated.
02
Drugs
interferon beta
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02117050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02117050.